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Introduction
• Complete skin exams (CSE’s) are 
frequently performed by dermatologists
• U.S. Preventive Forces Task Force does 
not currently recommend routine CSE’s
• Many primary care physicians do not 
regularly perform CSE’s
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Introduction
(continued)
• Current literature focuses on benefits of 
early detection of cutaneous neoplasms
• Multiple barriers to universal use
–Time constraints
–Lack of emphasis on CSE’s during training
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Goal of CSE’s
• Decrease morbidity, mortality, and costs
• Early detection of malignant melanoma, 
squamous cell and basal cell carcinomas, 
and pre-malignancies
• Melanomas are most worrisome and the 
5-year survival rate for those with a 
thickness of < 0.76 mm is 98%
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Malignant Melanoma
5
Squamous Cell Carcinoma
6
Basal Cell Carcinoma
7
Actinic keratosis
8
Dysplastic nevus
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Objectives
• Perform CSE’s on all new patients
• Determine number of patients with 
dermatologist-detected lesions
• Determine number of dermatologist-
detected consequential lesions defined as 
pre-malignant or malignant lesions
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Methods
• New patients presenting to UMass 
Medical Center dermatology clinic from 
10/2009 – 3/2010
• Varying ages, ethnicities, and sex
• Patients noted lesions of concern on a 
survey
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Methods
(continued)
• CSE performed on every patient
• Lesions noted by patient documented 
and treated appropriately
• Dermatologist-detected lesions 
documented and treated appropriately
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Results
Patients with lesions 10
Total Pts enrolled 53
Percent detected 18.87 %
Patients with dermatologist-
detected lesions
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Gender Breakdown
35
18
Total females
Total males
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Lesion Detection by Gender
Females with Detected 
Lesions
5
% of Total Females 14.29%
Males with Detected 
Lesions
5
% of Total Males 27.78%
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Dermatologist-detected
Consequential Lesions
Patients with 
Consequential Lesions
5
Total Patients 53
Percent of Total 9.43%
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Consequential Lesions
Pre-malignant/malignant 
Lesions
8
Total Lesions Detected 14
% Consequential of those 
Detected
57.14%
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Premalignant Lesions
Premalignant Lesions 6
% of Total Detected 42.86%
Clinical Diagnosis 3 (50%)
Pathologic Diagnosis 3 (50%)
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Malignant Lesions
Malignant Lesions 2
% of Total Detected 14.29%
Clinical Diagnosis 0 (0%)
Pathologic Diagnosis 2 (100%)
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Malignant Melanoma 0
Squamous Cell Carcinoma 0
Basal Cell Carcinoma 2
Actinic Keratosis 4
Dysplastic Nevus 2
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Discussion
• Focus on consequential premalignant & 
malignant lesions
• Goal to decrease morbidity & mortality
• One patient worked up for possible 
neurofibromatosis
• No statistical significance with detection 
of lesions based on gender
• Presence of limitations
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Limitations
• Small patient population surveyed
• Surveys not used in all clinics
• Small number of children included
• Twice as many females as males
• No breakdown based on Fitzpatrick skin 
type
26
Conclusion
• Pilot study
• CSE detected consequential lesions in 
9.4% of population surveyed
• Clinically significant results
• No statistical significance secondary to 
small population size
• Future large-scale study will include more 
children and adults of all ages, ethnicities, 
and gender 27
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